Moderate EvidencePromising research with growing clinical support from multiple studies
Alternatives for Alzheimer's Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked by memory loss, impaired thinking, and changes in behavior. Biologically, it involves abnormal accumulation of amyloid-beta plaques and tau tangles, synaptic dysfunction, and neuroinflammation. While Western medicine has clarified the biology and improved diagnostic accuracy with cerebrospinal fluid and blood biomarkers, amyloid/tau PET imaging, and structured cognitive testing, many families still face modest symptom relief, treatment side effects, and care burdens. These realities drive interest in “alternatives” — a broad umbrella that includes lifestyle strategies, nutraceuticals, neuromodulation, and traditional systems like Traditional Chinese Medicine (TCM) and Ayurveda.
From a Western perspective, several nonpharmacologic options have comparatively strong or moderate evidence. Regular physical activity (aerobic and resistance training) is consistently linked to better cognition and function in mild cognitive impairment (MCI) and early AD, potentially by improving cerebral blood flow, insulin sensitivity, and neurotrophic signaling. Dietary patterns such as Mediterranean and MIND diets emphasize vegetables, legumes, whole grains, fish, olive oil, and berries; observational and interventional studies suggest these patterns may slow cognitive decline and support brain health via vascular and anti-inflammatory pathways. Good sleep hygiene and treating sleep apnea can stabilize attention and memory and may reduce amyloid burden over time. Cognitive training and structured cognitive stimulation therapies can maintain daily function and selected cognitive domains. Hearing and vision correction, social engagement, and safe home environments all support quality of life.
Nutraceuticals attract attention but have mixed evidence. Omega-3 fatty acids (DHA/EPA) may benefit people with low dietary intake or earlier-stage cognitive changes, though large trials in established AD generally show no,
neurological
Updated March 17, 2026